Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more
Fleury S.A. (FLRY3) - Net Assets
Latest net assets as of December 2025: R$5.10 Billion BRL
Based on the latest financial reports, Fleury S.A. (FLRY3) has net assets worth R$5.10 Billion BRL as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$13.22 Billion) and total liabilities (R$8.12 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$5.10 Billion |
| % of Total Assets | 38.55% |
| Annual Growth Rate | 22.61% |
| 5-Year Change | 174.81% |
| 10-Year Change | 231.85% |
| Growth Volatility | 101.02 |
Fleury S.A. - Net Assets Trend (2006–2025)
This chart illustrates how Fleury S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fleury S.A. (2006–2025)
The table below shows the annual net assets of Fleury S.A. from 2006 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | R$5.10 Billion | -5.18% |
| 2024-12-31 | R$5.37 Billion | +5.16% |
| 2023-12-31 | R$5.11 Billion | +89.22% |
| 2022-12-31 | R$2.70 Billion | +45.65% |
| 2021-12-31 | R$1.85 Billion | +5.92% |
| 2020-12-31 | R$1.75 Billion | -0.46% |
| 2019-12-31 | R$1.76 Billion | +0.52% |
| 2018-12-31 | R$1.75 Billion | +2.55% |
| 2017-12-31 | R$1.71 Billion | +11.12% |
| 2016-12-31 | R$1.54 Billion | -7.23% |
| 2015-12-31 | R$1.66 Billion | +5.24% |
| 2014-12-31 | R$1.57 Billion | -6.87% |
| 2013-12-31 | R$1.69 Billion | -0.99% |
| 2012-12-31 | R$1.71 Billion | +4.54% |
| 2011-12-31 | R$1.63 Billion | +61.28% |
| 2010-12-31 | R$1.01 Billion | +20.60% |
| 2009-12-31 | R$838.97 Million | +452.54% |
| 2008-12-31 | R$151.84 Million | +49.82% |
| 2007-12-31 | R$101.35 Million | -4.31% |
| 2006-12-31 | R$105.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fleury S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 132.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | R$101.20 Million | 2.02% |
| Common Stock | R$2.74 Billion | 54.71% |
| Other Comprehensive Income | R$2.20 Billion | 43.98% |
| Total Equity | R$5.00 Billion | 100.00% |
Fleury S.A. Competitors by Market Cap
The table below lists competitors of Fleury S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
JINXIN FERT.GRP HD-00001
F:3NX
|
$536.60 Million |
|
Integra LifeSciences Holdings
NASDAQ:IART
|
$536.88 Million |
|
ADENTRA INC.
F:UQ0
|
$537.15 Million |
|
Care Property Invest NV
BR:CPINV
|
$537.19 Million |
|
Kuyas Yatirim AS
IS:KUYAS
|
$536.46 Million |
|
Tele Columbus AG
LSE:0R50
|
$536.46 Million |
|
Sdiptech AB
LSE:0AAV
|
$536.37 Million |
|
Shenyang Jinbei Automotive Co Ltd
SHG:600609
|
$536.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fleury S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,289,068,000 to 5,001,340,000, a change of -287,728,000 (-5.4%).
- Net income of 612,831,000 contributed positively to equity growth.
- Dividend payments of 513,054,999 reduced retained earnings.
- Other comprehensive income increased equity by 231,254,000.
- Other factors decreased equity by 618,758,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$612.83 Million | +12.25% |
| Dividends Paid | R$513.05 Million | -10.26% |
| Other Comprehensive Income | R$231.25 Million | +4.62% |
| Other Changes | R$-618.76 Million | -12.37% |
| Total Change | R$- | -5.44% |
Book Value vs Market Value Analysis
This analysis compares Fleury S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.69x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 42.18x to 1.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | R$0.37 | R$15.49 | x |
| 2007-12-31 | R$0.36 | R$15.49 | x |
| 2008-12-31 | R$0.56 | R$15.49 | x |
| 2009-12-31 | R$3.14 | R$15.49 | x |
| 2010-12-31 | R$3.63 | R$15.49 | x |
| 2011-12-31 | R$5.68 | R$15.49 | x |
| 2012-12-31 | R$5.15 | R$15.49 | x |
| 2013-12-31 | R$5.10 | R$15.49 | x |
| 2014-12-31 | R$4.76 | R$15.49 | x |
| 2015-12-31 | R$4.95 | R$15.49 | x |
| 2016-12-31 | R$4.44 | R$15.49 | x |
| 2017-12-31 | R$4.96 | R$15.49 | x |
| 2018-12-31 | R$5.12 | R$15.49 | x |
| 2019-12-31 | R$5.18 | R$15.49 | x |
| 2020-12-31 | R$5.16 | R$15.49 | x |
| 2021-12-31 | R$5.52 | R$15.49 | x |
| 2022-12-31 | R$7.91 | R$15.49 | x |
| 2023-12-31 | R$10.49 | R$15.49 | x |
| 2024-12-31 | R$9.72 | R$15.49 | x |
| 2025-12-31 | R$9.18 | R$15.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fleury S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.25%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.39%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 2.64x
- Recent ROE (12.25%) is below the historical average (14.26%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 32.68% | 6.59% | 1.50x | 3.32x | R$22.29 Million |
| 2007 | 26.18% | 4.59% | 1.09x | 5.23x | R$15.65 Million |
| 2008 | 27.85% | 6.21% | 1.09x | 4.09x | R$26.89 Million |
| 2009 | 9.96% | 10.85% | 0.61x | 1.50x | R$-319.90K |
| 2010 | 12.85% | 14.92% | 0.66x | 1.31x | R$28.82 Million |
| 2011 | 6.17% | 8.94% | 0.40x | 1.74x | R$-62.54 Million |
| 2012 | 6.25% | 7.10% | 0.55x | 1.61x | R$-64.00 Million |
| 2013 | 3.62% | 3.69% | 0.52x | 1.90x | R$-107.76 Million |
| 2014 | 5.45% | 5.11% | 0.52x | 2.04x | R$-71.49 Million |
| 2015 | 6.48% | 5.66% | 0.59x | 1.94x | R$-58.20 Million |
| 2016 | 14.90% | 10.91% | 0.70x | 1.96x | R$75.18 Million |
| 2017 | 18.79% | 13.45% | 0.68x | 2.07x | R$149.97 Million |
| 2018 | 18.95% | 12.44% | 0.68x | 2.23x | R$156.59 Million |
| 2019 | 17.76% | 10.75% | 0.57x | 2.90x | R$136.42 Million |
| 2020 | 14.68% | 8.65% | 0.54x | 3.15x | R$81.88 Million |
| 2021 | 18.96% | 9.04% | 0.64x | 3.29x | R$165.40 Million |
| 2022 | 11.48% | 6.90% | 0.57x | 2.91x | R$39.75 Million |
| 2023 | 8.34% | 6.55% | 0.56x | 2.28x | R$-84.59 Million |
| 2024 | 11.65% | 8.02% | 0.59x | 2.47x | R$87.27 Million |
| 2025 | 12.25% | 7.39% | 0.63x | 2.64x | R$112.70 Million |
Industry Comparison
This section compares Fleury S.A.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $420,434,000
- Average return on equity (ROE) among peers: -0.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fleury S.A. (FLRY3) | R$5.10 Billion | 32.68% | 1.59x | $536.55 Million |
| Centro de Imagem Diagnósticos S.A (AALR3) | $743.32 Million | -0.56% | 0.97x | $56.52 Million |
| Diagnósticos da América S.A (DASA3) | $97.55 Million | 0.00% | 0.62x | $665.76 Million |